March 18, 2025

Parafoveal Area of the Retina: A Biomarker for Systemic Diseases

Retinal thinning was linked to MS, type 2 diabetes, hypertension, and hyperlipidemia, among others.

Conexiant

March 17, 2025

How Spaceflight Alters Human Physiology

From bone loss to vision impairment, spaceflight triggers changes in human physiology.

Reuters

March 14, 2025

Study Demonstrates Outcomes of CNV Removal for hESC-RPE

“Safe CNV removal is a prerequisite for successful hESC-RPE transplantation in patients with wet AMD,” researchers found.

Conexiant

March 13, 2025

Study Assesses Eye Movement Impairment in Adults with Alcohol Use Disorder

Tolerance may explain why participants with AUD showed less impairment in smooth pursuit tasks, but not in saccadic movement.

Conexiant

March 13, 2025

Vision Improvements With Gene Therapy for Pediatric Retinal Dystrophy

After intervention, treated eyes showed improvements to a mean of 0.9 logMAR (range: 0.8–1.0), while untreated eyes became unmeasurable at final follow-up.

Conexiant

March 06, 2025

Private Equity Acquisitions Affect Industry Payments for Ophthalmologists

“It is unknown whether PE firms affect the financial incentives offered to physicians by other industry actors, which may change clinical decision-making," researchers note.

Conexiant

March 06, 2025

An Estimated 31 Million Americans Borrowed for Medical Bills in 2024

A new West Health-Gallup Survey survey reveals insights into medical debt across all income levels and demographics in the United States.

Conexiant

March 06, 2025

FDA Approves First Treatment for MacTel

Neurotech’s ocular insert Encelto aims to slow vision loss in patients with this degenerative retinal disease.

Retinal Physician

March 04, 2025

Uncertainties about Geographic Atrophy Complement Inhibition Therapy

Functional benefits and safety remain in question, despite anatomical benefits shown in trials.

Conexiant